Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03016065 · ClinicalTrials.gov registry record · NA
Efficacy of Pea Hull Fiber - Phase 2
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03016065: Completed NA study, sponsored by University of Florida.
NCT03016065 is a NA study that has completed, run by University of Florida. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03016065, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this randomized, cross-over study is to explore the effects of pea hull fiber on bowel movement frequency, transit time, appetite, gastrointestinal symptoms, microbiota composition and activity.
Primary Outcome
Stool consistency rating by Modified Bristol Stool Form for children
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT Pea Fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2022-11-15 |
| Phase | NA |
What the finished NCT03016065 record still lists
NCT03016065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03016065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03016065 about?
NCT03016065 is a clinical study titled "Efficacy of Pea Hull Fiber - Phase 2". The purpose of this randomized, cross-over study is to explore the effects of pea hull fiber on bowel movement frequency, transit time, appetite, gastrointestinal symptoms, microbiota composition and activity.
What is the current status of trial NCT03016065?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-03-29. Estimated completion is 2022-11-15.
What interventions are being tested in trial NCT03016065?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Pea Fiber (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03016065?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03016065's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI